Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer
NCT03100136
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuroinflammation
Interventions
DRUG:
[11C]PF-06809247
Sponsor
Pfizer